Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group.

Thriemer K, Ley B, Bobogare A, Dysoley L, Alam MS, Pasaribu AP, Sattabongkot J, Jambert E, Domingo GJ, Commons R, Auburn S, Marfurt J, Devine A, Aktaruzzaman MM, Sohel N, Namgay R, Drukpa T, Sharma SN, Sarawati E, Samad I, Theodora M, Nambanya S, Ounekham S, Mudin RN, Da Thakur G, Makita LS, Deray R, Lee SE, Boaz L, Danansuriya MN, Mudiyanselage SD, Chinanonwait N, Kitchakarn S, Nausien J, Naket E, Duc TN, Do Manh H, Hong YS, Cheng Q, Richards JS, Kusriastuti R, Satyagraha A, Noviyanti R, Ding XC, Khan WA, Swe Phru C, Guoding Z, Qi G, Kaneko A, Miotto O, Nguitragool W, Roobsoong W, Battle K, Howes RE, Roca-Feltrer A, Duparc S, Bhowmick IP, Kenangalem E, Bibit JA, Barry A, Sintasath D, Abeyasinghe R, Sibley CH, McCarthy J, von Seidlein L, Baird JK, Price RN.

Malar J. 2017 Apr 5;16(1):141. doi: 10.1186/s12936-017-1784-1. Review.

2.

Omics markers of the red cell storage lesion and metabolic linkage.

D'alessandro A, Nemkov T, Reisz J, Dzieciatkowska M, Wither MJ, Hansen KC.

Blood Transfus. 2017 Mar;15(2):137-144. doi: 10.2450/2017.0341-16. Review.

3.

Glucose-6-Phosphate Dehydrogenase: Update and Analysis of New Mutations around the World.

Gómez-Manzo S, Marcial-Quino J, Vanoye-Carlo A, Serrano-Posada H, Ortega-Cuellar D, González-Valdez A, Castillo-Rodríguez RA, Hernández-Ochoa B, Sierra-Palacios E, Rodríguez-Bustamante E, Arreguin-Espinosa R.

Int J Mol Sci. 2016 Dec 9;17(12). pii: E2069. Review.

4.

Alternatives to currently used antimalarial drugs: in search of a magic bullet.

Bhagavathula AS, Elnour AA, Shehab A.

Infect Dis Poverty. 2016 Nov 4;5(1):103. Review.

5.

Management of relapsing Plasmodium vivax malaria.

Chu CS, White NJ.

Expert Rev Anti Infect Ther. 2016 Oct;14(10):885-900. doi: 10.1080/14787210.2016.1220304. Epub 2016 Aug 31. Review.

6.

Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date.

Ebstie YA, Abay SM, Tadesse WT, Ejigu DA.

Drug Des Devel Ther. 2016 Jul 26;10:2387-99. doi: 10.2147/DDDT.S61443. eCollection 2016. Review.

7.

A pediatrician's practical guide to diagnosing and treating hereditary spherocytosis in neonates.

Christensen RD, Yaish HM, Gallagher PG.

Pediatrics. 2015 Jun;135(6):1107-14. doi: 10.1542/peds.2014-3516. Review.

8.

Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria.

Baird K.

Pathog Glob Health. 2015 May;109(3):93-106. doi: 10.1179/2047773215Y.0000000016. Review.

9.

Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.

Rajapakse S, Rodrigo C, Fernando SD.

Cochrane Database Syst Rev. 2015 Apr 29;(4):CD010458. doi: 10.1002/14651858.CD010458.pub2. Review.

10.

Dual Antiplatelet Therapy in Patients with Glucose-6-Phosphate Dehydrogenase Deficiency undergoing PCI with Drug-Eluting Stents.

Biscaglia S, Ferri A, Pavasini R, Campo G, Ferrari R.

J Atheroscler Thromb. 2015;22(5):535-41. doi: 10.5551/jat.29371. Epub 2015 Apr 3. Review.

11.

Triggers, inhibitors, mechanisms, and significance of eryptosis: the suicidal erythrocyte death.

Lang E, Lang F.

Biomed Res Int. 2015;2015:513518. doi: 10.1155/2015/513518. Epub 2015 Mar 4. Review.

12.

Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.

Graves PM, Gelband H, Garner P.

Cochrane Database Syst Rev. 2015 Feb 19;(2):CD008152. doi: 10.1002/14651858.CD008152.pub4. Review.

13.

Epistasis and the sensitivity of phenotypic screens for beta thalassaemia.

Penman BS, Gupta S, Weatherall DJ.

Br J Haematol. 2015 Apr;169(1):117-28. doi: 10.1111/bjh.13241. Epub 2014 Dec 17. Review.

14.

Managing the jaundiced newborn: a persistent challenge.

Maisels MJ.

CMAJ. 2015 Mar 17;187(5):335-43. doi: 10.1503/cmaj.122117. Epub 2014 Nov 10. Review. No abstract available.

15.

Primaquine: the risks and the benefits.

Ashley EA, Recht J, White NJ.

Malar J. 2014 Nov 3;13:418. doi: 10.1186/1475-2875-13-418. Review.

16.

Reexamining the risks of drinking-water nitrates on public health.

Richard AM, Diaz JH, Kaye AD.

Ochsner J. 2014 Fall;14(3):392-8. Review.

17.

G6PD deficiency in Latin America: systematic review on prevalence and variants.

Monteiro WM, Val FF, Siqueira AM, Franca GP, Sampaio VS, Melo GC, Almeida AC, Brito MA, Peixoto HM, Fuller D, Bassat Q, Romero GA, Maria Regina F O, Marcus Vinícius G L.

Mem Inst Oswaldo Cruz. 2014 Aug;109(5):553-68. Epub 2014 Aug 19. Review.

18.

Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission.

Graves PM, Gelband H, Garner P.

Cochrane Database Syst Rev. 2014 Jun 30;(6):CD008152. doi: 10.1002/14651858.CD008152.pub3. Review. Update in: Cochrane Database Syst Rev. 2015;(2):CD008152.

19.

Malaria parasites and red cell variants: when a house is not a home.

Taylor SM, Fairhurst RM.

Curr Opin Hematol. 2014 May;21(3):193-200. doi: 10.1097/MOH.0000000000000039. Review.

20.

Clinical complications of G6PD deficiency in Latin American and Caribbean populations: systematic review and implications for malaria elimination programmes.

Monteiro WM, Franca GP, Melo GC, Queiroz AL, Brito M, Peixoto HM, Oliveira MR, Romero GA, Bassat Q, Lacerda MV.

Malar J. 2014 Feb 25;13:70. doi: 10.1186/1475-2875-13-70. Review.

Supplemental Content

Loading ...
Support Center